Sanofi (SNY) Reports Positive Results in Phase 3 trial for Toujeo in Children & Adolescents with Type 1 Diabetes; CHMP Adopts Positive Opinion for Expanded Indication

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BLDR

Go back to Sanofi (SNY) Reports Positive Results in Phase 3 trial for Toujeo in Children & Adolescents with Type 1 Diabetes; CHMP Adopts Positive Opinion for Expanded Indication
SANOFI (NASDAQ: SNY) Delayed: 44.24 -0.09 (0.2%)
Previous Close $44.33    52 Week High $44.76 
Open $44.17    52 Week Low $36.81 
Day High $44.36    P/E N/A 
Day Low $44.03    EPS $0.00 
Volume 1,695,048